Official UK visa sponsor profile for Corvus Learning Trust in Sandhurst, including current register status, route details, and public company data.
Corvus Learning Trust is a private-limited-guarant-nsc-limited-exemption biopharmaceutical company dedicated to advancing cancer treatment through innovative clinical research and drug development. Established in 2017, the trust operates from its Sandhurst School facility in GU47 0SD, UK. Corvus focuses on the discovery, development, and commercialization of novel medicines targeting challenging cancers, prioritizing patient outcomes. The company’s core mission centers on creating medicines with precise mechanisms of action, aiming to address unmet medical needs within the oncology space. Corvus’s research and development efforts are driven by a commitment to improving the quality of life for individuals battling debilitating cancers. Currently, Corvus is a skilled worker visa holder, rated as a Worker (A rating) with a focus on international collaboration and strategic partnerships. The company’s activities encompass a range of clinical trials and research initiatives, leveraging a dedicated team of scientists and clinicians. Corvus’s international presence is currently limited, but actively exploring opportunities for collaboration and expansion. The company’s SIC codes include: - 85200: Primary education - 85310: General secondary education - 85411: Pharmaceutical research and development - 85412: Clinical research and development - 85413: Biotechnology - 85414: Medical device development - 85415: Pharmaceutical manufacturing.
Official UK visa sponsor profile for Corvus Learning Trust in Sandhurst, including current register status, route details, and public company data.
Corvus Learning Trust is a private-limited-guarant-nsc-limited-exemption biopharmaceutical company dedicated to advancing cancer treatment through innovative clinical research and drug development. Established in 2017, the trust operates from its Sandhurst School facility in GU47 0SD, UK. Corvus focuses on the discovery, development, and commercialization of novel medicines targeting challenging cancers, prioritizing patient outcomes. The company’s core mission centers on creating medicines with precise mechanisms of action, aiming to address unmet medical needs within the oncology space. Corvus’s research and development efforts are driven by a commitment to improving the quality of life for individuals battling debilitating cancers. Currently, Corvus is a skilled worker visa holder, rated as a Worker (A rating) with a focus on international collaboration and strategic partnerships. The company’s activities encompass a range of clinical trials and research initiatives, leveraging a dedicated team of scientists and clinicians. Corvus’s international presence is currently limited, but actively exploring opportunities for collaboration and expansion. The company’s SIC codes include: - 85200: Primary education - 85310: General secondary education - 85411: Pharmaceutical research and development - 85412: Clinical research and development - 85413: Biotechnology - 85414: Medical device development - 85415: Pharmaceutical manufacturing.
Yes, Corvus Learning Trust is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Corvus Learning Trust is classified under: Primary education, General secondary education.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Corvus Learning Trust is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Corvus Learning Trust is classified under: Primary education, General secondary education.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.